Jeffrey T. L. Smith, Senior VP Translational Medicine at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 3,000 shares at $32.47 ($97K) on 2016-09-01, disclosed to the SEC on 2016-09-06.
Open-market sale of $97k ALDR by Senior VP Translational Medicine. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.47 | 2,900 | $94K | 96.6% |
| 2 | $33.10 | 100 | $3K | 3.4% |
| Total | $32.49 avg | 3,000 | $97K | 100% |
| Filing → |
| ZYME | SELL | 2025-01-06 | $332K | — | Filing → |
| ALDR | SELL | 2019-09-18 | $1.2M | — | Filing → |
| ALDR | SELL | 2018-12-04 | $140K | — | Filing → |